BRCA2
EstablishedBRCA2 germline mutations confer hereditary cancer risk across multiple organs and determine PARP inhibitor treatment eligibility.
BRCA2 works alongside BRCA1 to repair DNA and, when mutated, raises cancer risk across several organs. There's a genuinely important extra consideration for family planning: if both parents carry a BRCA2 mutation and pass it to a child, that child can develop a separate, serious inherited condition called Fanconi anemia.
BRCA2 is a tumor suppressor gene working alongside BRCA1 in homologous recombination DNA repair; germline pathogenic variants increase lifetime risk of breast, ovarian, prostate, and pancreatic cancer, with a distinct additional consideration for reproductive planning.
BRCA2 pathogenic variants confer elevated lifetime cancer risk across multiple sites and determine PARP inhibitor eligibility, similar to BRCA1; BRCA2-associated breast cancers are less consistently triple-negative than BRCA1-associated cancers, a subtle but clinically relevant distinction between the two genes.
Detected via the same germline or somatic testing approaches as BRCA1, often as part of the same combined test; genetic counseling should specifically note that inheriting two BRCA2 pathogenic variants (one from each parent) causes Fanconi anemia, a serious inherited bone marrow failure condition, relevant information for patients of childbearing age with a known BRCA2 mutation.
PARP inhibitors (olaparib, rucaparib, niraparib, talazoparib) are FDA-approved for BRCA1/2-mutated ovarian, breast, pancreatic, and prostate cancers; metastatic prostate cancer patients with BRCA2 mutations show particularly strong PARP inhibitor responses in some analyses, an area of active clinical refinement.
Biallelic (two-copy) inheritance causes Fanconi anemia, an important reproductive counseling consideration distinct from BRCA1.
- Oncology Nursing Society. (2024). Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers.
- NCI. BRCA Gene Changes: Cancer Risk and Genetic Testing Fact Sheet.